Determination of IGFs and their binding proteins

Research output: Contribution to journalJournal articleResearchpeer-review


The worldwide clinical and scientific interest in peptides belonging to the insulin-like growth factor (IGF) system has brought along a call for standardization of assays used to quantify the different IGF related proteins. This relates in particular to the measurement of IGF-I, which has stood the test of time as an important biochemical tool in the diagnosis and treatment of growth hormone (GH) related disorders. The first international consensus statement on the measurement of IGF-I in 2011 represents an important milestone and will undoubtedly improve commutability of reference ranges for IGF-I and clinically applicable cut-off values. By contrast, there is no consensus addressing the measurements of the other IGF-related peptides. Nevertheless, measurement of these peptides may be of interest, either as additional tools in GH disorders or as prognostic biomarkers of various diseases. Therefore, standardization of assays for the other IGF-related peptides is highly relevant. This chapter discusses the recent consensus on IGF-I measurements and how this approach may be applied to measurement of the other IGF-related peptides. In addition, assay pitfalls, pre- and post-analytical challenges, alternative methods for IGF-I measurements and potential assays of tomorrow will be discussed.

Original languageEnglish
JournalBest Practice & Research: Clinical Endocrinology & Metabolism
Issue number6
Pages (from-to)771-781
Number of pages11
Publication statusPublished - Dec 2013


  • IGF-I
  • assay development
  • consensus statement
  • immunoassay
  • post-analytical
  • pre-analytical


Dive into the research topics of 'Determination of IGFs and their binding proteins'. Together they form a unique fingerprint.

Cite this